₨ 4,532
Out of stock
Menactra Injection (meningococal Vaccine) is a Meningitis Vaccine designed to protect against infections caused by Neisseria meningitidis bacteria. Meningococcal diseases, including meningitis and septicemia, can be severe and potentially life-threatening. Menactra helps stimulate the immune system to produce a protective response against these bacteria.
The vaccine primarily targets four major serogroups of Neisseria meningitidis: A, C, Y, and W-135. These serogroups are known for causing the majority of meningococcal disease cases.
Menactra is indicated for active immunization to prevent invasive meningococcal disease in individuals aged 9 months through 55 years. It is particularly important for adolescents and young adults, as they are at an increased risk of meningococcal infections.
The vaccine is typically administered via intramuscular injection.
The dosage and schedule may vary based on age, vaccination history, and specific health considerations. Healthcare providers follow established immunization schedules for optimal protection.
Common side effects may include pain or redness at the injection site, mild fever, and fatigue. Serious adverse reactions are rare.
Individuals with a history of severe allergic reactions to the vaccine components or a previous dose should consult their healthcare provider. Additionally, the vaccine may not be suitable for those with certain medical conditions.
Note: This information provides a general overview and is not a substitute for professional medical advice. Individuals should consult their healthcare provider for personalized guidance regarding Menactra Injection and its administration.
You must be logged in to post a review.
No account yet?
Create an Account
Reviews
Clear filtersThere are no reviews yet.